These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
114 related items for PubMed ID: 9495638
21. Insulin resistance and essential hypertension: pathophysiologic and therapeutic implications. Santucci A, Ferri C. J Hypertens Suppl; 1992 Apr; 10(2):S9-15. PubMed ID: 1593308 [Abstract] [Full Text] [Related]
22. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy. Khan NA, McAlister FA, Campbell NR, Feldman RD, Rabkin S, Mahon J, Lewanczuk R, Zarnke KB, Hemmelgarn B, Lebel M, Levine M, Herbert C, Canadian Hypertension Education Program. Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142 [Abstract] [Full Text] [Related]
23. ACE inhibitors versus AT1 blockers in the treatment of hypertension and syndrome X. Feldman R. Can J Cardiol; 2000 Aug; 16 Suppl E():41E-44E. PubMed ID: 10906626 [Abstract] [Full Text] [Related]
26. Metabolic syndrome: treatment of hypertensive patients. Israili ZH, Lyoussi B, Hernández-Hernández R, Velasco M. Am J Ther; 2007 Aug; 14(4):386-402. PubMed ID: 17667215 [Abstract] [Full Text] [Related]
27. Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors. Fournier A, Oprisiu-Fournier R, Serot JM, Godefroy O, Achard JM, Faure S, Mazouz H, Temmar M, Albu A, Bordet R, Hanon O, Gueyffier F, Wang J, Black S, Sato N. Expert Rev Neurother; 2009 Sep; 9(9):1413-31. PubMed ID: 19769454 [Abstract] [Full Text] [Related]
28. [Antihypertensive agents and the risk of new onset diabetes mellitus]. Kuzmanić D, Laganović M, Dika Z, Kos J, Pećin I. Lijec Vjesn; 2006 Sep; 128(11-12):336-41. PubMed ID: 17212194 [Abstract] [Full Text] [Related]
29. [Are the newer antihypertensive agents better and more effective than diuretics?]. Landmark K. Tidsskr Nor Laegeforen; 2001 Feb 28; 121(6):701-5. PubMed ID: 11293353 [Abstract] [Full Text] [Related]
30. New treatment guidelines for a patient with diabetes and hypertension. Mogensen CE. J Hypertens Suppl; 2003 Mar 28; 21(1):S25-30. PubMed ID: 12769164 [Abstract] [Full Text] [Related]
31. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR. Clin Ther; 2007 Sep 28; 29(9):1803-24. PubMed ID: 18035185 [Abstract] [Full Text] [Related]
33. [Influence of risk factors and pharmacological treatment on mortality in patients with essential hypertension]. Román O, Cuevas G, Bunout D. Rev Med Chil; 1998 Jul 28; 126(7):745-52. PubMed ID: 9830766 [Abstract] [Full Text] [Related]
36. The effect of ACE inhibitors and other antihypertensive agents on insulin resistance. Lithell H. Nephrol Dial Transplant; 1995 Jul 28; 10(5):589-91. PubMed ID: 7566564 [No Abstract] [Full Text] [Related]
38. Effects of ACE inhibitors and calcium channel blockers on insulin sensitivity and other components of the syndrome. Sowers JR. Nephrol Dial Transplant; 1995 Oct 28; 10 Suppl 9():52-5. PubMed ID: 8643209 [No Abstract] [Full Text] [Related]